Devi G. Nair Enrolls First US Patient in Smartphone Camera Atrial Fibrillation Detection Study
Devi G Nair, Chief of Cardiac Electrophysiology and Research at St. Bernard’s Healthcare, shared Happitech’s post on LinkedIn:
“Proud of our team at St. Bernards Healthcare and the Arrhythmia Research Group for enrolling the first US patient in the Happitech smartphone PPG AF study.
In northeast Arkansas, AF too often announces itself as a stroke. If we can find it earlier, with a phone our patients already carry, we can change that story.
For communities far from a cardiologist, accessible screening could mean earlier diagnosis and earlier stroke prevention.
Proud to help generate the evidence.
Thank you to Happitech for partnering with a community program, and to our patients for helping move this question forward.”
Happitech shared a post on LinkedIn:
“Dr. Devi Nair and her team at St. Bernards have enrolled the first patient in Happitech’s US smartphone-based AF study.
In northeast Arkansas, too many of Dr. Devi G Nair patients first learn they have atrial fibrillation after a stroke.
Many live an hour or more from the nearest cardiologist. Nearly all of them carry a smartphone.
In her words:
‘A tool that could flag an irregular heart rhythm using the camera already in a patient’s pocket with no additional device to buy, wear or charge, could help us identify AF between clinic visits and get patients on stroke-preventing therapy sooner.’
The study, Detection of Atrial Fibrillation Using Photoplethysmography from Smartphone Cameras (NCT07779213), will test whether Happitech’s investigational Heart Rhythm Software can reliably meet that need.
Each participant has one extra, non-invasive PPG recording taken alongside their standard-of-care 12-lead ECG. Their clinical care stays the same.
Four sites in the United States and one in the Netherlands are enrolling patients.
The data are intended to support a future FDA 510(k) submission.
Thank you to Dr. Nair and the team at St. Bernards Healthcare and the Arrhythmia Research Group for enrolling the first patient and getting the study under way.
Dr. Devi Nair is Chief of Cardiac Electrophysiology and Research at St. Bernards Healthcare and CEO of the Arrhythmia Research Group, Jonesboro, Arkansas.
Caution: Investigational device. Limited by United States law to investigational use.
Not cleared or approved by the US FDA.”
Stay updated with Hemostasis Today.
-
Nov 20, 2026, 00:14Saskia de Pee: Fortified Rice Cuts Anemia Risk by 57%
-
Nov 20, 2026, 00:02Andres Zuleta: Evaluating the RISE UP Trial Results on Mitapivat for Sickle Cell Disease
-
Nov 19, 2026, 23:57Greta Hametner: Preventing Maternal Cardiac Complications Through Preconception Iron and Thyroid Screening
-
Nov 19, 2026, 23:49Cyrus Shariat: Why Waiting for Lab Results Can Be Fatal in HIT
-
Nov 19, 2026, 22:24Erik Nelson: Low Iron Can Raise A1c without Changing Blood Sugar
-
Nov 19, 2026, 22:23Erwin Loh: Daily Iron Supplementation Reduces Iron-Deficiency Anaemia in Children and Adolescents
-
Nov 19, 2026, 22:22Afifah Sardar: Why Can a Simple Painkiller like Aspirin Make You Bleed More?
-
Nov 19, 2026, 22:16Jonathan Penm: Perioperative Anticoagulation Management and Antithrombotic Stewardship Across 31 Countries
-
Nov 19, 2026, 22:15Salomao V.: Innovation in Hemophilia A Is Also About How Patients Receive Their Treatment